drugset / Trial / NCT07202871

A Study of How the Body Absorbs LY3537031

NCT07202871

Phase 1 Active not recruiting 46 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelBasic science

Summary

The main purpose of this study is to find out how much LY3537031 gets into the blood stream and how long it takes the body to get rid of it when it is injected just under the skin in different parts of the body, and when it is injected into a vein, in healthy participants. This study will also look at the safety and tolerability of LY3537031.

Timeline

Start
2025-11-03
Primary completion
2026-09
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject LY3537031 Unknown Subcutaneous

Indications

No indication recorded.